Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-20
DOI
10.1038/s41418-020-0491-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma
- (2019) Tan Boon Toh et al. JOURNAL OF HEPATOLOGY
- The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer
- (2018) Harvey R. Fernandez et al. CELL DEATH AND DIFFERENTIATION
- The longevity gene INDY ( I 'm N ot D ead Y et) in metabolic control: Potential as pharmacological target
- (2018) Diana M. Willmes et al. PHARMACOLOGY & THERAPEUTICS
- Combination of Mitochondrial and Plasma Membrane Citrate Transporter Inhibitors Inhibits De Novo Lipogenesis Pathway and Triggers Apoptosis in Hepatocellular Carcinoma Cells
- (2018) Wan-angkan Poolsri et al. Biomed Research International
- The Mitochondrial Citrate Carrier (SLC25A1) Sustains Redox Homeostasis and Mitochondrial Metabolism Supporting Radioresistance of Cancer Cells With Tolerance to Cycling Severe Hypoxia
- (2018) Julian Hlouschek et al. Frontiers in Oncology
- A Drosophila model of combined D-2- and L-2-hydroxyglutaric aciduria reveals a mechanism linking mitochondrial citrate export with oncometabolite accumulation
- (2018) Hongde Li et al. Disease Models & Mechanisms
- The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2018) Konstantin Kazankov et al. Nature Reviews Gastroenterology & Hepatology
- Current and future pharmacological therapies for NAFLD/NASH
- (2017) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- An overview of combined D-2- and L-2-hydroxyglutaric aciduria: functional analysis of CIC variants
- (2017) Ana Pop et al. JOURNAL OF INHERITED METABOLIC DISEASE
- The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications
- (2017) Anna Alisi et al. MEDIATORS OF INFLAMMATION
- Quantitative metabolic flux analysis reveals an unconventional pathway of fatty acid synthesis in cancer cells deficient for the mitochondrial citrate transport protein
- (2017) Lei Jiang et al. METABOLIC ENGINEERING
- Road to stemness in hepatocellular carcinoma
- (2017) Teresita NJ Flores-Téllez et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Discoveries, metabolic roles and diseases of mitochondrial carriers: A review
- (2016) Ferdinando Palmieri et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
- (2016) Yaron Rotman et al. GUT
- The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival
- (2016) Sandra Mattu et al. JOURNAL OF HEPATOLOGY
- Reductive carboxylation supports redox homeostasis during anchorage-independent growth
- (2016) Lei Jiang et al. NATURE
- Chronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese Mice
- (2016) Ana Luisa Gavito et al. PLoS One
- Current efforts and trends in the treatment of NASH
- (2015) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- The role of INDY in metabolism, health and longevity
- (2015) Ryan P. Rogers et al. Frontiers in Genetics
- Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease
- (2015) Sanja Stojsavljević WORLD JOURNAL OF GASTROENTEROLOGY
- The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis.
- (2015) Olga Catalina-Rodriguez et al. Oncotarget
- SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.
- (2015) Vamsi K. Kolukula et al. Oncotarget
- A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation
- (2014) Vittoria Infantino et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Dietary Fat and Hepatic Lipogenesis: Mitochondrial Citrate Carrier as a Sensor of Metabolic Changes
- (2014) Alessandra Ferramosca et al. Advances in Nutrition
- Hepatic Monoacylglycerol O-acyltransferase 1 as a Promising Therapeutic Target for Steatosis, Obesity, and Type 2 Diabetes
- (2014) Yasuhiro Hayashi et al. Molecular Therapy-Nucleic Acids
- Deficiency in SLC25A1, Encoding the Mitochondrial Citrate Carrier, Causes Combined D-2- and L-2-Hydroxyglutaric Aciduria
- (2013) Benjamin Nota et al. AMERICAN JOURNAL OF HUMAN GENETICS
- What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
- (2013) J.-A. Losman et al. GENES & DEVELOPMENT
- Agenesis of corpus callosum and optic nerve hypoplasia due to mutations inSLC25A1encoding the mitochondrial citrate transporter
- (2013) Simon Edvardson et al. JOURNAL OF MEDICAL GENETICS
- Changes in Mitochondrial Carriers Exhibit Stress-Specific Signatures in INS-1Eβ-Cells Exposed to Glucose Versus Fatty Acids
- (2013) Thierry Brun et al. PLoS One
- Dietary downregulation of mutant p53 levels via glucose restriction
- (2012) Olga Catalina Rodriguez et al. CELL CYCLE
- A conditional knockout resource for the genome-wide study of mouse gene function
- (2011) William C. Skarnes et al. NATURE
- Inhibitors of the Mitochondrial Citrate Transport Protein: Validation of the Role of Substrate Binding Residues and Discovery of the First Purely Competitive Inhibitor
- (2009) S. Aluvila et al. MOLECULAR PHARMACOLOGY
- Mitochondrial localization and function of a subset of 22q11 deletion syndrome candidate genes
- (2008) T.M. Maynard et al. MOLECULAR AND CELLULAR NEUROSCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started